Kaishan Tao
127 Changle Road
Xi'an, 710032, China
Xi'an, 710032, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 73 publications
A multi-centre, prospective trial of a methylation-based liquid biopsy for early detection of liver cancer in high-risk populations.
Journal: Clinical and translational medicine
Published: January 12, 2026
Chinese expert consensus on conversion and perioperative therapy of primary liver cancer (2024 edition).
Journal: Hepatobiliary surgery and nutrition
Published: February 28, 2025
Chinese expert consensus on sequential surgery following conversion therapy based on combination of immune checkpoint inhibitors and antiangiogenic targeted drugs for advanced hepatocellular carcinoma (2024 edition).
Journal: Bioscience trends
Published: December 25, 2024
Assessing the Impact of Multidisciplinary Team (MDT) Care on Patients with Liver Cancer/Cirrhosis: A Systematic Review and Meta-Analysis.
Journal: Iranian journal of public health
Published: September 10, 2024
Plasma exchange and intravenous immunoglobulin prolonged the survival of a porcine kidney xenograft in a sensitized, brain-dead human recipient.
Journal: Chinese medical journal
Published: June 25, 2024
Chinese guidelines for minimally invasive donor hepatectomy in living donor liver transplantation (2024 edition).
Journal: Hepatobiliary surgery and nutrition
Published: June 24, 2024
A prospective randomized controlled study of antibiotic bone cement in the treatment of diabetic foot ulcer
Journal: Zhonghua shao shang yu chuang mian xiu fu za zhi
Published: October 08, 2023
A COMPARATIVE ANALYSIS TO DETERMINE THE OPTIMUM HISTONE DEACETYLASE INHIBITORS AND ADMINISTRATION ROUTE FOR IMPROVING SURVIVAL AND ORGAN INJURY IN RATS AFTER HEMORRHAGIC SHOCK.
Journal: Shock (Augusta, Ga.)
Published: May 04, 2023
Retraction Note: PTBP3 splicing factor promotes hepatocellular carcinoma by destroying the splicing balance of NEAT1 and pre-miR-612.
Journal: Oncogene
Published: March 08, 2023
Clinical efficacy and safety evaluation of camrelizumab plus lenvatinib in adjuvant therapy after hepatocellular carcinoma surgery.
Journal: Frontiers in oncology
Published: February 27, 2023
Last Updated: 09/26/2026